Fate Therapeutics - 48 Year Dividend History | FATE

Historical dividend payout and yield for Fate Therapeutics (FATE) since 1971. The current TTM dividend payout for Fate Therapeutics (FATE) as of June 18, 2019 is $0.00. The current dividend yield for Fate Therapeutics as of June 18, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.246B $0.005B
Fate Therapeutics, Inc. is a biopharmaceutical company. The company focused on the discovery and development of adult stem cell modulators to treat hematologic malignancies, lysosomal storage disorders and muscular dystrophies. Fate Therapeutics, Inc. is headquartered in San Diego, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.806B 12.30
Gilead Sciences (GILD) United States $85.546B 10.39
Bio-Techne Corp (TECH) United States $7.848B 53.55